Alembic Pharmaceuticals consolidated net profit rises 36.74% in the June 2019 quarter

Capital Market 

Sales rise 10.01% to Rs 948.91 crore

Net profit of Alembic Pharmaceuticals rose 36.74% to Rs 123.72 crore in the quarter ended June 2019 as against Rs 90.48 crore during the previous quarter ended June 2018. Sales rose 10.01% to Rs 948.91 crore in the quarter ended June 2019 as against Rs 862.53 crore during the previous quarter ended June 2018. ParticularsQuarter EndedJun. 2019Jun. 2018% Var.Sales948.91862.53 10 OPM %23.7017.51 -PBDT223.22149.52 49 PBT187.82121.92 54 NP123.7290.48 37

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Mon, July 29 2019. 16:59 IST